Summary:
Consider this Clinical Research Study
Living with systemic sclerosis, also known as scleroderma, can be physically and emotionally painful.
There is a clinical research study underway to investigate the treatment for patients whose scleroderma has also led to interstitial lung disease, a life-threatening disorder caused by excess scarring - known as fibrosis - in the lungs.
If you have been diagnosed with systemic sclerosis and interstitial lung disease, consider participation in this research study.
You may qualify for this research
study if you:
- Are between the ages of 18 and 80
- Have been diagnosed with systemic
sclerosis (scleroderma)
- Meet specific pulmonary function testing
requirements
You may not qualify for this
research study if you:
- Have another inflammatory connective
tissue disease (e.g., rheumatoid arthritis,
systemic lupus)
- Have a known history of
obstructive lung disease or other
respiratory disorders
- Have a history of a blood clot or a family
history of blood clots
- Are pregnant or nursing
- Tested positive for hepatitis or HIV
Qualified Participants May Receive:
Reimbursement for expenses if travel is required to participate